Back

High CHADsVASc and NO AF: any indication for anticoagulation?

20 June 2017 (15:07 - 15:30)
Organised by:
Congress Presentation Part of: Stroke and bleeding in atrial fibrillation: difficult management issues Miscellaneous EHRA Premium Access EHRA EUROPACE - CARDIOSTIM 2017

About the speaker

Photo
Professor Tatjana Potpara

School of Medicine, Belgrade University, Belgrade (Serbia)

3 More presentations in this session

Presentation thumbnail
Acute bleeding in an AF patient on NOAC: how to use reversal agents appropriately?
Doctor I. Savelieva (London, GB)
Slides Video
Presentation thumbnail
Anticoagulation after catheter ablation: is stoping anticoagulation really a good idea in CADsVASc >2?
Doctor H. Calkins (Baltimore, US)
Slides Video
Presentation thumbnail
Acute ischaemic stroke in AF patient on a NOAC: Thrombolysis, thrombectomy or pray? And what to do next ?
Professor H. Haring (Linz, AT)
Slides Video

Access the full session

Session thumbnail
Stroke and bleeding in atrial fibrillation: difficult management issues

The Event

Event poster

EHRA EUROPACE - CARDIOSTIM 2017

20 June 2017 15:07 CET
You may be interested in
thumbnail
Congress Presentation
Should we initiate oral anticoagulants for patients with atrial fibrillation staying well without oral anticoagulants for years?
28 August 2022
thumbnail
Congress Presentation
1 September 2019
thumbnail
Congress Presentation
Clinical significance of echocardiographic left ventricular hypertrophy for predicting left atrial appendage thrombotic milieu in patients with atrial fibrillation and CHA2DS2-VASc scores of 0-2
31 August 2024
thumbnail
Congress Presentation
Dual-axis utility mapping (HAS-BLED x CHA2DS2-VA) after acute heart failure with atrial fibrillation: late bleeding hazard and a calibration-checked decision grid
12 April 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources